{"id": "1366540314190753793", "creation": 1614643574.0, "user_id": "2563262155", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 1, "like_count": 3, "quote_count": 0}}, "text": "#vaccine developer Inovio Pharmaceuticals Inc said on Monday it had completed Phase II enrolment for a mid-to-late stage U.S. trial of its #COVID19 vaccine candidate and expects to report data early in the second quarter. $INO #SARSCoV2 #IN04800 https://t.co/0V411AhShk", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19", "#SARSCOV2", "#IN04800"]}